The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Traded today… if this continues we will have all the warrants out of the way this week… also good to see no impact and the price holding. Once out of the way we will start to see a significant rise into the news. Gla
Being more realistic I believe we will double our yearly high of 0.1325 looking more like 0.26 on Trial results. Will be more than happy with that. As a lot have mentioned JN just getting started with Vela… if people hang in here 3-4 yrs we would see a lot of rich people on here retiring early. Happy days
Also another good thing to point out is… if the trial was unsuccessful we would have had the report done and dusted by now… they would not need to spend as much time ensuring each minor detail is concluded. Part of this report will tie in details of the commercialisation which as stated in previous RNS is in progress. So close now… not worried about the minor fluctuation in sp at present will just get excited to see what the results do to it.
No marketing needed for an investment company Hector.. the marketing is done by the companies they invest in… albeit very little out there anoint the trial… will be a Big Bang on success… everything pointing towards that and commercialisation already in progress. Hopefully as soon as results out they will hit the ground running on good news. Not long now
We did get the initial results (or rather SGS did) via data sent to the data analysts to be used to compile the final results from all the patients in all the hospitals that had signed up. Think we all assumed it would be initial results for us investors. The RNS could have been worded better maybe. Either way not long to wait now!!
Caddy can you explain what reason you invested in Vela was it the SGS investment or JN or something else… I cant see what you mean by it’s failed it’s investors… I for one am happy. I followed JN and more than happy with his progress.